ロテプレドノール
“Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1”. Journal of Cataract and Refractive Surgery 24 (11): 1480–9. (November 1998). doi:10.1016/s0886-3350(98)80170-3. PMID 9818338.